Increased nasal airflow resistance (NAR) may contribute to the development of upper airway obstruction during sleep, 1 and several studies have reported snoring and obstructive
Diagnosis
Objective: To examine the serum levels of leptin and adiponectin in different obstructive sleep apnea (OSA) phenotypes
Obstructive sleep apnea is a sleep-related breathing disorder that has been linked directly to cardiovascular issues, and indirectly to cancer, diabetes, and dementia
Study design: We conducted a randomized, triple-blind, placebocontrolled, parallel-group trial of nasal fluticasone propionate versus placebo in 25 children aged 1 to 10 years with obstructive sleep apnea proven on polysomnography
Expand
OBJECTIVE We tested the hypothesis that a 6-week course of a nasal glucocorticoid spray would decrease the severity of obstructive sleep
When severe, OSA prevents restful sleep
The signs of OSA include daytime drowsiness, narcolepsy, cognitive impairment, and snoring while sleeping
Childhood obstructive sleep apnea (OSA) syndrome is characterized by episodic upper airway obstruction that occurs during sleep
The following are the local side effects of inhaled corticosteroids in children with asthma
The most common underlying reason for OSA in childhood are enlarged adenoids or tonsils
The primary outcome was the change from baseline in the frequency of mixed and obstructive apneas and hypopneas
This reduction could contribute to the clinical efficacy of this class of medications in the treatment of childhood obstructive sleep apnea syndrome
et al
Untreated OSA can lead to a variety of complications and adverse consequences mainly due to intermittent hypoxemia
Intranasal corticosteroids have not been shown to
Snoring noise and sleep quality were unchanged but daily diary records indicated subjective improvements in nasal congestion and daytime alertness with fluticasone (p<0